Banque de Luxembourg’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$156K Sell
370
-131
-26% -$52.2K 0.07% 63
2026
Q2
$181K Hold
501
– – 0.09% 58
2026
Q1
$176K Hold
501
– – 0.09% 56
2025
Q4
$164K Hold
501
– – 0.07% 64
2025
Q3
$141K Sell
501
-100
-17% -$29K 0.07% 59
2025
Q2
$187K Hold
601
– – 0.11% 50
2025
Q1
$187K Hold
601
– – 0.11% 50
2024
Q4
$157K Hold
601
– – 0.08% 54

Other funds holding AMGN

Banque de Luxembourg's AMGN Position: Q3 2026 in Review

Banque de Luxembourg reduced its Amgen (AMGN) stake by 26% in Q3 2026, selling an estimated $52.2K and leaving 370 shares worth $156K. The position accounts for 0.07% of the portfolio, ranked #63.

Banque de Luxembourg first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $187K in Q2 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Banque de Luxembourg held 370 shares of Amgen worth $156K as of Q3 2026.
  • Banque de Luxembourg sold 131 Amgen shares in Q3 2026, an estimated $52.2K.
  • Amgen made up 0.07% of Banque de Luxembourg's portfolio in Q3 2026, its #63 holding.
  • Banque de Luxembourg first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Banque de Luxembourg's Amgen position peaked at $187K in Q2 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Banque de Luxembourg's 13F filing for Q3 2026, filed 14 Oct 2026.